(Q34316468)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11468019%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

0 references

1 reference

title

Beta-blocker treatment in heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11468019%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11468019%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

A Bouzamondo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11468019%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

P Sanchez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11468019%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M Cucherat

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11468019%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

P Lechat

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11468019%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 April 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11468019%20AND%20SRC:MED&resulttype=core&format=json

Fundamental and Clinical Pharmacology

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11468019%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11468019%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11468019%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

95-109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11468019%20AND%20SRC:MED&resulttype=core&format=json

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2001.00019.X

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2001.00019.X

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2001.00019.X

A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2001.00019.X

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2001.00019.X

Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2001.00019.X

Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2001.00019.X

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2001.00019.X

Treatment of heart failure with celiprolol, a cardioselective beta blocker with beta-2 agonist vasodilatory properties. The CELICARD Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2001.00019.X

Usefulness of bucindolol in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2001.00019.X

Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2001.00019.X

Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2001.00019.X

Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2001.00019.X

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2001.00019.X

Platelet activation and coronary stent implantation. Effect of antithrombotic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2001.00019.X

Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2001.00019.X

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2001.00019.X

Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2001.00019.X

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2001.00019.X

10.1046/J.1472-8206.2001.00019.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11468019%20AND%20SRC:MED&resulttype=core&format=json

release_rh7as5kxznghfjagp3prxtbyme

9 November 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rh7as5kxznghfjagp3prxtbyme

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference